Yao C, Zhang X, Hong Q and Lin W
Tuberculosis (TB), as a kind of chronic infectious disease by Mycobacterium Tuberculosis (Mtb), is one of the most common causes of death worldwide. The strategy of anti-TB therapy has improved during the last decades following the development of agents against TB and advanced exploration of TB. However, accompanied with the medical progression, Multidrug-Resistant TB (MDR-TB) has also emerged which causes higher mortality and morbidity due to multiply factors from clinical treatment, epidemiology and compliance of patients including drug abusing, irregular schedules and gene mutations. Therefore, we present a case of TB with rifampin-resistance in this article to explore risk factors of drug-resistance.
PDFShare this article
Journal of Clinical Case Reports received 1295 citations as per Google Scholar report
